Country: United Kingdom
Language: English
Source: HMA (Heads of Medicines Agencies)
amoxicillin (as trihydrate) 14 w/v, Clavulanic Acid (as potassium clavulate) 3.5 w/v
Norbrook Laboratories Limited
Suspension for injection
Cattle
2011-08-17
Revised: August 2011 AN: 00927/2010 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Combisyn Suspension for Injection (United Kingdom) Noroclav Suspension for Injection (France) Noroclav Suspension for Injection (Portugal) Noroclav 175 mg Suspension for Injection (Spain) Noroclav Injection (Belgium, Italy) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1ml supplies: ACTIVE SUBSTANCE: Amoxicillin (as Amoxicillin trihydrate) 140 mg Clavulanic acid (as Potassium clavulanate) 35 mg EXCIPIENTS: Butylated hydroxyanisole (E320) 0.08 mg Butylated hydroxytoluene (E321) 0.08 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Suspension for injection. An off-white to cream oily suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In Cattle: Treatment of respiratory infections due to _Pasteurella multocida_ and _Mannheimia haemolytica_. In Dogs: Respiratory tract infections, urinary tract infections, skin and soft tissue infections (e.g. abscesses, pyoderma, anal sacculitis and gingivitis Revised: August 2011 AN: 00927/2010 Page 2 of 7 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to penicillin or other substances of the beta-lactam group. Do not use in animals with serious dysfunction of kidneys accompanied by anuria or oliguria. Do not use in rabbits, guinea pigs, hamsters or gerbils. The use of the product is contraindicated where resistance to the combination of penicillins or other Read the complete document